A banking crisis that started in the United States this month with Silicon Valley Bank and spread to Europe with the Swiss government-orchestrated sale of Credit Suisse Group AG to UBS Group AG roiled markets and stopped many deals in their tracks, investment bankers and lawyers said.

Through the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic versions of cabotegravir LA for PrEP, in 90 countries, subject to required regulatory approvals. Aurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.

However, the API sale process, which was launched a couple of months ago, has seen no serious buyers, added multiple people aware of the development. The company has been seeking a valuation of $600-700 million (₹5,000 crore) for the API business and hired Jefferies to run the sale process.

With a post-COVID record profit, Pfizer is looking to double down on cancer treatments in anticipation of the upcoming surge in cases.

"The market is now expecting that the Fed is likely to not raise rates this month and so they may enter a pause period," said Peter Cardillo, chief market economist at Spartan Capital Securities.

All three main stock indexes climbed more than 1% shortly after the opening bell, in part due to an easing in Treasury yields, and all three closed well off their session highs.

Anand Rathi is bullish on Pfizer India has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated February 10, 2023.

Food delivery giant Zomato's net loss widened to Rs 347 core compared with a loss of 63 crore a year ago. Consolidated revenue from operations surged 75% on year to Rs 1,948 crore.

Consumer inflation data will be closely monitored on Tuesday, and is expected to show prices increased by 7.3% in November on an annual basis, slowing from the 7.7% rise in the previous month, while the "core" reading which excludes food and energy is expected to show a 6.1% increase from the 6.3% in the prior month.

U.S. stock indexes rallied to kick off the trading week on Monday, lifted in part by gains in Microsoft and Pfizer, as investors girded for inflation data on Tuesday and a policy announcement from the Federal Reserve later in the week.

Pfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals sector.

ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4505 in its research report dated November 17, 2022.

Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20569.10 Crore) operating in Pharmaceuticals sector.

The Fed is expected to raise interest rates another three-quarters of a percentage point at its upcoming meeting in November. Markets have been unsettled partly because investors have been hoping that any sign of inflation easing or economic growth slowing could signal that the Fed will ease up on its rate increases, which have yet to show any signs of significantly impacting inflation.

Indicators and oscillators like MACD (moving average convergence and divergence) and RSI have turned bullish on the weekly charts. KIMS is placed above all important moving averages, indicating bullish trend on all time frames.

And whenever there is a rally in US markets, India is outperforming reflecting the resilience of Indian economy and markets. Investors should not be carried away by the rallies because there are major challenges for the global economy and markets.

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022.

Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 19287.47 Crore) operating in Pharmaceuticals sector.

Recently on a weekly scale, Gujarat Gas confirmed a bullish Inverted Hammer candlestick pattern followed by a bullish Piercing pattern exactly at the mentioned support levels and that is adding more confirmation of further upside in the counter.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer jab as a booster for those aged 12 and over after a "careful review of the evidence". The UK regulator last month okayed a similar bivalent vaccine by Moderna, becoming the first country to do so. MHRA chief executive June Raine said: "I am pleased to announce that we now have a second approved vaccine for the UK Autumn booster programme."

It will include a mix of newly-approved jabs adapted for the now dominant Omicron strain, and the original vaccines developed to fight the virus that first emerged in China in 2019, the European Medicines Agency (EMA) said. But people "should not wait for a specific vaccine", EMA vaccines chief Marco Cavaleri told a news conference.

​​Streptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.

The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries.

Chief Medical Advisor to the President of United States Dr Anthony Fauci advises people to get shots for Covid and flu ASAP. He also plans to encourage HIV shots. While alarming citizens, he asks the US to pay heed to the warning signs.

The first lady of United States, Jill Biden, has tested positive for COVID-19 again, the White House said on Wednesday.

Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before COVID-19 emerged in 2019 and exploded into global consciousness in early 2020. Moderna has also been sued for patent infringement in the United States and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.

A combination of undersupply of vaccines and treatments, underfunding of health systems, undervaluing of health workers, and poor adaptation to local needs were the key drivers behind low vaccination rates, informed researchers studying communities in 14 low and middle-income countries and territories.

According to a TOI report, indigenously-manufactured vaccines have started to capture share from MNCs in certain diseases even as the Rs 3,000 crore private market plummeted sharply by 15% in June month-on-month, one of the sharpest such declines in recent years.

In its latest weekly assessment of the COVID-19 pandemic, the U.N. health agency said there were 5.3 million new cases and more than 14,000 deaths reported last week. WHO said the number of new infections declined in every world region except the Western Pacific.

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche. With the Frenchman at the helm, the fortunes of the Anglo-Swedish drugmaker changed dramatically.

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche.

Pfizer and BioNTech's vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a similar immune response to those seen in older age groups. An early analysis based on 10 symptomatic COVID-19 cases in the study had suggested a vaccine efficacy of 80.3% in this group.

Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.

A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an independent monitoring panel found no signs of it working. "All other studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued," Sanofi said.

Pfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.

Make in India can be made better by shifting focus to employment in more labour-intensive industries, increasing India's global trade competitiveness and by GoI fully embracing an ancillary 'Innovate in India' campaign focused on facilitating India's rise as a global R&D hub and generating employment for high-skill workers.

He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.

After twenty years, there is a possibility that a vaccine against Lyme disease will be ready. People are being tested for its efficacy in both Europe and the USA.

ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4480 in its research report dated August 06, 2022.

Revenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period.The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.

The order of the bivalent shot follows the announcement last month that the federal government had secured 105 million doses of a similar vaccine from rival drugmaker Pfizer. Both orders are scheduled for delivery in the fall and winter, assuming regulators sign off on their effectiveness. The Pentagon said the Moderna contract was worth $1.74 billion.

​​The company said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment option for patients with mild to moderate symptoms of Covid-19. While the price of medicine is yet to be decided, it will be manufactured at Zenara's USFDA-approved state-of-the-art facility in Hyderabad.

The approval by the Central Drugs Standard Control Organization (CDSCO) has been granted under the emergency authorization route considering the unmet medical need.

The company said that Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19 will be available soon.

White House Press Secretary Karine Jean-Pierre said that Biden was experiencing "mild symptoms" and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of the disease.

The researchers used records on 1,951,866 (19.5 lakh) and 3,219,349 (32 lakh) adults who had received two doses of Pfizer and AstraZeneca vaccnes, respectively and 2,422,980 (24 lakh) unvaccinated adults.